home / stock / mdgef / mdgef message board
Subject | By | Source | When |
---|---|---|---|
dhovekamp42: Attention will come with this 1st commercial TCR immunotherapy deal of German Medigene | dhovekamp42 | investorshangout | 09/29/2016 8:02:37 AM |
News, Short Squeeze, Breakout and More Instantly...
Medigene Ag Ord Company Name:
MDGEF Stock Symbol:
OTCMKTS Market:
Planegg/Martinsried, April 26, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the f...
Planegg/Martinsried, April 25, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents a comprehensive overview of its...
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, has been invited to present at the CHI's 8 th Annual Immuno-Oncology Summit Europe fr...